发现抗病毒药物的成功策略 1559条(本栏目收费,不能显示细节,电话13136136841)
cyclopropyl analogues 228,229 229
2'-cyclopropyl nucleoside ester prodrugs 427 427
cyclopropylacylsulfonamide 208 208
arrow RSV604 RSV non-fusion inhibitor 49,50,51,57 57
artificial bilayer systems 300 300
aspartic proteases 453 453
AstraZeneca 9,10,41,46 46
asunaprevir (BMS-650032) 16,17,191,192 192
atazanavir (ATV) 459,472 472
ATV/RTV/FTC/TDF 491,495 495
atriplas three-drug combination 156,157,472 472
(2-[3-azaspiro(5,5)undecanol]-2-imidazoline) (BL-1743) 305,317 317
AZD-2836 HCV NS5A replication complex inhibitor candidate 10,18 18
AZD-7295 HCV NS5A replication complex inhibitor candidate 10,18 18
azide-containing NS5A inhibitors 21,22 22
bacterial systems 301 301
balapiravir (R1479) 75 75
BALB/c mouse model 32,40,41,42,45,46,87 87
BENCHMRK 1/2 trial 154,155 155
benzimidazole 40,44,46 46
BMS-433771 RSV fusion inhibitor 40,43,44,46 46
BMS-488043 prodrug 440,441 441
BMS-650032 (asunaprevir) 16,17,191,192 192
BMS-663068 prodrug 442 442
BMS-663749 prodrug 441,442 442
BMS-791325,discovery 261,262 262
BMS-986094 (formerly INX-189) 324,436,438 438